title: Neurotensin activates GABAergic interneurons in the prefrontal cortex.
abstract: Converging data suggest a dysfunction of prefrontal cortical GABAergic interneurons in schizophrenia. Morphological and physiological studies indicate that cortical GABA cells are modulated by a variety of afferents. The peptide transmitter neurotensin may be one such modulator of interneurons. In the rat prefrontal cortex (PFC), neurotensin is exclusively localized to dopamine axons and has been suggested to be decreased in schizophrenia. However, the effects of neurotensin on cortical interneurons are poorly understood. We used in vivo microdialysis in freely moving rats to assess whether neurotensin regulates PFC GABAergic interneurons. Intra-PFC administration of neurotensin concentration-dependently increased extracellular GABA levels; this effect was impulse dependent, being blocked by treatment with tetrodotoxin. The ability of neurotensin to increase GABA levels in the PFC was also blocked by pretreatment with 2-[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazole-3-yl)carbonylamino]tricyclo(3.3.1.1 [EC] .3.7)decan-2-carboxylic acid (SR48692), a high-affinity neurotensin receptor 1 (NTR1) antagonist. This finding is consistent with our observation that NTR1 was localized to GABAergic interneurons in the PFC, particularly parvalbumin-containing interneurons. Because neurotensin is exclusively localized to dopamine axons in the PFC, we also determined whether neurotensin plays a role in the ability of dopamine agonists to increase extracellular GABA levels. We found that D2 agonist-elicited increases in PFC GABA levels were blocked by pretreatment with SR48692, consistent with data indicating that D2 autoreceptor agonists increase neurotensin release from dopamine-neurotensin axons in the PFC. These findings suggest that neurotensin plays an important role in regulating prefrontal cortical interneurons and that it may be useful to consider neurotensin agonists as an adjunct in the treatment of schizophrenia.
authors.affiliation: Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, USA.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Petrie
authors.forename: Dennis
authors.initials: D
authors.lastname: Schmidt
authors.forename: Michael
authors.initials: M
authors.lastname: Bubser
authors.forename: Jim
authors.initials: J
authors.lastname: Fadel
authors.forename: Robert E
authors.initials: RE
authors.lastname: Carraway
authors.forename: Ariel Y
authors.initials: AY
authors.lastname: Deutch
mesh_terms: D000818:Animals; D001369:Axons / Q000378:metabolism; D004298:Dopamine / Q000502:physiology; D018491:Dopamine Agonists / Q000494:pharmacology; D007395:Interneurons / Q000187:drug effects* / Q000502:physiology; D008297:Male; D017551:Microdialysis; D009496:Neurotensin / Q000378:metabolism / Q000494:pharmacology*; D010320:Parvalbumins / Q000032:analysis; D017397:Prefrontal Cortex / Q000166:cytology / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D019257:Quinpirole / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000819:agonists; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors; D012559:Schizophrenia / Q000378:metabolism; D013779:Tetrodotoxin / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000032:analysis / Q000502:physiology*
chemical_list: D018491:Dopamine Agonists; D010320:Parvalbumins; D011720:Pyrazoles; D011804:Quinolines; D017448:Receptors, Dopamine D2; D018028:Receptors, Neurotensin; C114036:neurotensin type 1 receptor; C079087:SR 48692; D019257:Quinpirole; D009496:Neurotensin; D013779:Tetrodotoxin; D005680:gamma-Aminobutyric Acid; D004298:Dopamine
references.citation: Biol Psychiatry. 1999 Aug 1;46(3):340-51
references.pmid: 10435199
references.citation: Neuroscience. 1999;93(2):441-8
references.pmid: 10465426
references.citation: Am J Psychiatry. 1999 Nov;156(11):1709-19
references.pmid: 10553733
references.citation: Arch Gen Psychiatry. 2000 Mar;57(3):237-45
references.pmid: 10711910
references.citation: Brain Res Bull. 2000 Oct;53(3):339-45
references.pmid: 11113590
references.citation: Am J Psychiatry. 2001 Feb;158(2):256-65
references.pmid: 11156808
references.citation: J Chem Neuroanat. 2001 Jul;22(1-2):95-100
references.pmid: 11470557
references.citation: J Neurosci Methods. 2001 Aug 15;109(1):31-9
references.pmid: 11489297
references.citation: Brain Res Bull. 2002 Mar 15;57(5):623-30
references.pmid: 11927365
references.citation: Neuroscience. 2002;111(2):379-87
references.pmid: 11983323
references.citation: Eur J Neurosci. 1992;4(12):1309-1319
references.pmid: 12106394
references.citation: J Neural Transm (Vienna). 2002 May;109(5-6):881-9
references.pmid: 12111475
references.citation: Physiol Behav. 2002 Dec;77(4-5):501-5
references.pmid: 12526990
references.citation: J Comp Neurol. 2003 Jul 7;461(4):483-505
references.pmid: 12746864
references.citation: J Comp Neurol. 2003 Jul 7;461(4):520-38
references.pmid: 12746866
references.citation: Neuropsychopharmacology. 2003 Aug;28(8):1400-11
references.pmid: 12784105
references.citation: J Neurosci. 2003 Jul 16;23(15):6315-26
references.pmid: 12867516
references.citation: J Neurochem. 1992 Nov;59(5):1967-70
references.pmid: 1328536
references.citation: Brain Res Mol Brain Res. 1992 Oct;15(3-4):332-8
references.pmid: 1331689
references.citation: Ann N Y Acad Sci. 1992;668:232-52
references.pmid: 1361115
references.citation: Prog Neurobiol. 1992 Dec;39(6):563-607
references.pmid: 1410442
references.citation: Neuroscience. 1992 Sep;50(2):259-68
references.pmid: 1436492
references.citation: J Pharmacol Exp Ther. 2003 Nov;307(2):640-50
references.pmid: 14570823
references.citation: Neuropsychopharmacology. 2004 Oct;29(10):1878-88
references.pmid: 15150532
references.citation: J Neurosci. 1991 Sep;11(9):2694-702
references.pmid: 1880545
references.citation: Brain Res. 1991 Apr 26;547(1):37-52
references.pmid: 1907216
references.citation: Am J Psychiatry. 1991 Apr;148(4):484-8
references.pmid: 2006695
references.citation: Brain Res. 1991 Feb 1;540(1-2):311-4
references.pmid: 2054626
references.citation: Brain Res. 1990 Oct 22;530(2):181-95
references.pmid: 2265353
references.citation: Neurosci Lett. 1990 Jan 1;108(1-2):143-8
references.pmid: 2304623
references.citation: Exp Brain Res. 1989;78(2):358-68
references.pmid: 2599044
references.citation: Neuropeptides. 1988 Apr;11(3):95-100
references.pmid: 3133572
references.citation: Exp Brain Res. 1987;68(2):277-89
references.pmid: 3319664
references.citation: Neuropharmacology. 1987 Aug;26(8):1053-9
references.pmid: 3658117
references.citation: Arch Gen Psychiatry. 1986 Feb;43(2):114-24
references.pmid: 3947207
references.citation: Biol Psychiatry. 1980 Apr;15(2):283-302
references.pmid: 6106513
references.citation: Am J Psychiatry. 1982 Sep;139(9):1122-6
references.pmid: 6126127
references.citation: J Comp Neurol. 1984 Feb 1;222(4):543-59
references.pmid: 6365985
references.citation: Schizophr Res. 1994 Apr;12(1):35-41
references.pmid: 7517175
references.citation: Mol Pharmacol. 1994 Jul;46(1):115-21
references.pmid: 7520123
references.citation: Cereb Cortex. 1993 May-Jun;3(3):223-38
references.pmid: 7686795
references.citation: Arch Gen Psychiatry. 1995 Apr;52(4):258-66
references.pmid: 7702443
references.citation: Mol Pharmacol. 1995 May;47(5):1050-6
references.pmid: 7746272
references.citation: Biochem J. 1995 Jan 1;305 ( Pt 1):277-83
references.pmid: 7826341
references.citation: Neuroscience. 1994 Jun;60(3):649-57
references.pmid: 7936192
references.citation: J Comp Neurol. 1994 Mar 15;341(3):407-19
references.pmid: 8195468
references.citation: Biochem Biophys Res Commun. 1994 Jan 14;198(1):400-7
references.pmid: 8292048
references.citation: Eur J Pharmacol. 1993 Jan 4;244(1):99-101
references.pmid: 8380559
references.citation: Peptides. 1993 Jan-Feb;14(1):37-45
references.pmid: 8382811
references.citation: J Neurophysiol. 1993 Jul;70(1):387-96
references.pmid: 8395585
references.citation: Neurosci Lett. 1995 Nov 10;200(1):9-12
references.pmid: 8584271
references.citation: J Comp Neurol. 1995 Dec 11;363(2):264-80
references.pmid: 8642074
references.citation: Psychiatry Res. 1995 Nov 29;59(1-2):81-96
references.pmid: 8771223
references.citation: J Neurosci. 1996 Sep 15;16(18):5613-20
references.pmid: 8795617
references.citation: J Comp Neurol. 1996 Sep 09;373(1):76-89
references.pmid: 8876464
references.citation: Neuroscience. 1996 Dec;75(4):1021-31
references.pmid: 8938738
references.citation: Anat Embryol (Berl). 1996 Dec;194(6):533-43
references.pmid: 8957530
references.citation: J Comp Neurol. 1997 Jan 27;377(4):465-99
references.pmid: 9007187
references.citation: Schizophr Res. 1997 Apr 11;24(3):349-55
references.pmid: 9134596
references.citation: J Physiol. 1997 May 1;500 ( Pt 3):689-713
references.pmid: 9161986
references.citation: Cereb Cortex. 1997 Jun;7(4):347-58
references.pmid: 9177765
references.citation: Br J Pharmacol. 1997 Jun;121(4):705-10
references.pmid: 9208137
references.citation: Schizophr Bull. 1997;23(3):437-58
references.pmid: 9327508
references.citation: Eur J Pharmacol. 1997 Sep 3;334(1):49-53
references.pmid: 9346327
references.citation: Eur J Neurosci. 1997 Sep;9(9):1838-46
references.pmid: 9383206
references.citation: J Mol Neurosci. 1997 Oct;9(2):93-102
references.pmid: 9407390
references.citation: Physiol Rev. 1998 Jan;78(1):189-225
references.pmid: 9457173
references.citation: J Chem Neuroanat. 1997 Dec;14(1):1-19
references.pmid: 9498163
references.citation: J Pharmacol Exp Ther. 1998 Apr;285(1):350-7
references.pmid: 9536031
references.citation: Life Sci. 1998;62(23):PL 375-80
references.pmid: 9627096
references.citation: J Neurosci. 1998 Sep 1;18(17):6977-89
references.pmid: 9712666
references.citation: J Biol Chem. 1998 Oct 9;273(41):26273-6
references.pmid: 9756851
references.citation: Cereb Cortex. 1998 Oct-Nov;8(7):614-22
references.pmid: 9823482
references.citation: Neurochem Int. 1998 Oct;33(4):335-40
references.pmid: 9840224
references.citation: Eur J Pharmacol. 1998 Nov 6;360(2-3):265-72
references.pmid: 9851594
references.citation: J Comp Neurol. 1998 Dec 28;402(4):475-500
references.pmid: 9862322